pharmaceutical preparations namely pharmaceutical preparations for the treatment of alzheimer's disease, anxiety disorders, atopic dermatitis, autoimm Read More

Classification Information

Class [005]
Pharmaceutical preparations namely pharmaceutical preparations for the treatment of Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease and dementia, neurological disorders namely mild cognitive impairment, and multiple sclerosis, pain relief, Parkinson's disease, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases

Classification kind code

Mark Details

Serial Number

1847915

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 50 on 21^st Nov 2018	Allowed
Submitted for opposition 51 on 21^st Nov 2018	Allowance Notice Sent
Submitted for opposition 42 on 08^th Aug 2018	Advertised
Submitted for opposition 26 on 19^th Jul 2018	Approved
Submitted for opposition 27 on 28^th May 2018	Approval Notice Sent
Submitted for opposition 22 on 15^th Sep 2017	Search Recorded
Submitted for opposition 20 on 15^th Sep 2017	Examiner's First Report
Submitted for opposition 31 on 20^th Jul 2017	Formalized
Submitted for opposition 1 on 18^th Jul 2017	Created
Submitted for opposition 30 on 17^th Jul 2017	Filed